Loading…
efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models
In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated th...
Saved in:
Published in: | World journal of microbiology & biotechnology 2009-04, Vol.25 (4), p.679-686 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3 |
container_end_page | 686 |
container_issue | 4 |
container_start_page | 679 |
container_title | World journal of microbiology & biotechnology |
container_volume | 25 |
creator | Koley, Hemanta Barman, Soumik Roy, Nivedita Saha, Dhira Rani Kumar, Ranajit |
description | In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future. |
doi_str_mv | 10.1007/s11274-008-9937-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_36354766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1642212677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</originalsourceid><addsrcrecordid>eNqFkU-L1TAUxYso-Bz9AK4MguKmmty0SbOUwX8w4GKcdUjTm04ebfJM-kb67U3poOBiXAVyf-fk3Jyqesnoe0ap_JAZA9nUlHa1UlzW4lF1YK3kNVUSHlcHqlpV8zJ6Wj3L-UhpUSl-qO7QOW-NXYkJA_HzfA5xxOCtX1YSHTFk8ndIlmRCtjEcz6MJC7ld--QHksu1Dxt2fetHnCZDhjVjWDB5U0TrCQkjhVh-xeLvZzOROQ445efVE2emjC_uz4vq5vOnH5df66vvX75dfryqbSOapeYAErAxrB8sSlSNlR0XrRKqF7bpJXLROXQDCkDVOid4K1lLlYDe9U3X84vq7e57SvHnGfOiZ5_tljRgPGfNi6KRQvwXBMY5cN4V8N2DIBMNAAMhZUFf_4Me4zmFsq8GAAqdACgQ2yGbYs4JnT6l8lFp1YzqrVq9V6tLtXqrVm9h39wbm2zN5Eo51uc_wvI8cMo3DnYul1EYMf0N8JD5q13kTNRmTMX45hoo45QJCgoU_w0z0LzC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222028622</pqid></control><display><type>article</type><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><source>ABI/INFORM Global</source><source>Springer Nature</source><creator>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</creator><creatorcontrib>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</creatorcontrib><description>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</description><identifier>ISSN: 0959-3993</identifier><identifier>EISSN: 1573-0972</identifier><identifier>DOI: 10.1007/s11274-008-9937-6</identifier><language>eng</language><publisher>Dordrecht: Dordrecht : Springer Netherlands</publisher><subject>Animal models ; Animals ; Applied Microbiology ; Bacterial infections ; Biochemistry ; Biological and medical sciences ; Biomedical and Life Sciences ; Biosynthesis ; Biotechnology ; Cholera ; Colon ; Developing countries ; Drug resistance ; Environmental Engineering/Biotechnology ; Epidemics ; Fundamental and applied biological sciences. Psychology ; Genes ; Immune response ; Immunization ; Immunogenicity ; Ketamine ; LDCs ; Life Sciences ; Mathematical analysis ; Mice ; Microbiology ; Original Paper ; Rabbits ; Salmonella ; Sanitation ; Serums ; Shigella ; Shigella dysenteriae ; Shigellosis ; Strain ; Studies ; Vaccines ; Virulence</subject><ispartof>World journal of microbiology & biotechnology, 2009-04, Vol.25 (4), p.679-686</ispartof><rights>Springer Science+Business Media B.V. 2008</rights><rights>2009 INIST-CNRS</rights><rights>Springer Science+Business Media B.V. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</citedby><cites>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/222028622/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/222028622?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,11667,27901,27902,36037,36038,44339,74638</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21223036$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Koley, Hemanta</creatorcontrib><creatorcontrib>Barman, Soumik</creatorcontrib><creatorcontrib>Roy, Nivedita</creatorcontrib><creatorcontrib>Saha, Dhira Rani</creatorcontrib><creatorcontrib>Kumar, Ranajit</creatorcontrib><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><title>World journal of microbiology & biotechnology</title><addtitle>World J Microbiol Biotechnol</addtitle><description>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</description><subject>Animal models</subject><subject>Animals</subject><subject>Applied Microbiology</subject><subject>Bacterial infections</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biosynthesis</subject><subject>Biotechnology</subject><subject>Cholera</subject><subject>Colon</subject><subject>Developing countries</subject><subject>Drug resistance</subject><subject>Environmental Engineering/Biotechnology</subject><subject>Epidemics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes</subject><subject>Immune response</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Ketamine</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Mathematical analysis</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Original Paper</subject><subject>Rabbits</subject><subject>Salmonella</subject><subject>Sanitation</subject><subject>Serums</subject><subject>Shigella</subject><subject>Shigella dysenteriae</subject><subject>Shigellosis</subject><subject>Strain</subject><subject>Studies</subject><subject>Vaccines</subject><subject>Virulence</subject><issn>0959-3993</issn><issn>1573-0972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNqFkU-L1TAUxYso-Bz9AK4MguKmmty0SbOUwX8w4GKcdUjTm04ebfJM-kb67U3poOBiXAVyf-fk3Jyqesnoe0ap_JAZA9nUlHa1UlzW4lF1YK3kNVUSHlcHqlpV8zJ6Wj3L-UhpUSl-qO7QOW-NXYkJA_HzfA5xxOCtX1YSHTFk8ndIlmRCtjEcz6MJC7ld--QHksu1Dxt2fetHnCZDhjVjWDB5U0TrCQkjhVh-xeLvZzOROQ445efVE2emjC_uz4vq5vOnH5df66vvX75dfryqbSOapeYAErAxrB8sSlSNlR0XrRKqF7bpJXLROXQDCkDVOid4K1lLlYDe9U3X84vq7e57SvHnGfOiZ5_tljRgPGfNi6KRQvwXBMY5cN4V8N2DIBMNAAMhZUFf_4Me4zmFsq8GAAqdACgQ2yGbYs4JnT6l8lFp1YzqrVq9V6tLtXqrVm9h39wbm2zN5Eo51uc_wvI8cMo3DnYul1EYMf0N8JD5q13kTNRmTMX45hoo45QJCgoU_w0z0LzC</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Koley, Hemanta</creator><creator>Barman, Soumik</creator><creator>Roy, Nivedita</creator><creator>Saha, Dhira Rani</creator><creator>Kumar, Ranajit</creator><general>Dordrecht : Springer Netherlands</general><general>Springer Netherlands</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>7U9</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L7M</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>7T5</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope></search><sort><creationdate>20090401</creationdate><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><author>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Applied Microbiology</topic><topic>Bacterial infections</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biosynthesis</topic><topic>Biotechnology</topic><topic>Cholera</topic><topic>Colon</topic><topic>Developing countries</topic><topic>Drug resistance</topic><topic>Environmental Engineering/Biotechnology</topic><topic>Epidemics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes</topic><topic>Immune response</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Ketamine</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Mathematical analysis</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Original Paper</topic><topic>Rabbits</topic><topic>Salmonella</topic><topic>Sanitation</topic><topic>Serums</topic><topic>Shigella</topic><topic>Shigella dysenteriae</topic><topic>Shigellosis</topic><topic>Strain</topic><topic>Studies</topic><topic>Vaccines</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koley, Hemanta</creatorcontrib><creatorcontrib>Barman, Soumik</creatorcontrib><creatorcontrib>Roy, Nivedita</creatorcontrib><creatorcontrib>Saha, Dhira Rani</creatorcontrib><creatorcontrib>Kumar, Ranajit</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Biological Sciences</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><jtitle>World journal of microbiology & biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koley, Hemanta</au><au>Barman, Soumik</au><au>Roy, Nivedita</au><au>Saha, Dhira Rani</au><au>Kumar, Ranajit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</atitle><jtitle>World journal of microbiology & biotechnology</jtitle><stitle>World J Microbiol Biotechnol</stitle><date>2009-04-01</date><risdate>2009</risdate><volume>25</volume><issue>4</issue><spage>679</spage><epage>686</epage><pages>679-686</pages><issn>0959-3993</issn><eissn>1573-0972</eissn><abstract>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</abstract><cop>Dordrecht</cop><pub>Dordrecht : Springer Netherlands</pub><doi>10.1007/s11274-008-9937-6</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-3993 |
ispartof | World journal of microbiology & biotechnology, 2009-04, Vol.25 (4), p.679-686 |
issn | 0959-3993 1573-0972 |
language | eng |
recordid | cdi_proquest_miscellaneous_36354766 |
source | ABI/INFORM Global; Springer Nature |
subjects | Animal models Animals Applied Microbiology Bacterial infections Biochemistry Biological and medical sciences Biomedical and Life Sciences Biosynthesis Biotechnology Cholera Colon Developing countries Drug resistance Environmental Engineering/Biotechnology Epidemics Fundamental and applied biological sciences. Psychology Genes Immune response Immunization Immunogenicity Ketamine LDCs Life Sciences Mathematical analysis Mice Microbiology Original Paper Rabbits Salmonella Sanitation Serums Shigella Shigella dysenteriae Shigellosis Strain Studies Vaccines Virulence |
title | efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A50%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=efficacy%20and%20immunogenicity%20of%20a%20live%20transconjugant%20hybrid%20strain%20of%20Shigella%20dysenteriae%20type%201%20in%20two%20animal%20models&rft.jtitle=World%20journal%20of%20microbiology%20&%20biotechnology&rft.au=Koley,%20Hemanta&rft.date=2009-04-01&rft.volume=25&rft.issue=4&rft.spage=679&rft.epage=686&rft.pages=679-686&rft.issn=0959-3993&rft.eissn=1573-0972&rft_id=info:doi/10.1007/s11274-008-9937-6&rft_dat=%3Cproquest_cross%3E1642212677%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222028622&rft_id=info:pmid/&rfr_iscdi=true |